PRESS RELEASES

Canada's Largest Cardiac Centre Receives VMS+ 3.0 Ventripoint Whole Heart Analysis System

November 5, 2020

November 3, 2020

Ventripoint Engages Oak Hill Financial to Provide Investor Relations Services and Approval of Warrant Amendment

September 28, 2020

October 9, 2020

Ventripoint Makes Application to Amend Warrants
Ventripoint Announces Appointment to the Board of Directors and Option
Grants

September 30, 2020

September 25, 2020

Ventripoint Engages Torrey Hills Capital to Provide Investor Relations Services

Ventripoint Installs Whole Heart Analysis System in MD Anderson Cancer Center
in Houston

October 8, 2020

Ventripoint Remotely Installs Whole Heart Analysis System in Major European Hospital

September 28, 2020

Ventripoint To Resume Trading at the Market Opening Friday, September 25, 2020

September 23, 2020

Ventripoint Provides Corporate Update and Enters Review by TSXV to Resume Trading

September 15, 2020

Ventripoint Announces Closing of Second Tranche of Non-Brokered Secured Convertible Debenture Unit Private Placement

September 14, 2020

September 15, 2020

Ventripoint Diagnostics Announces U.S. FDA Clearance for VMS+ 3.0 Whole Heart Analysis System

October 17, 2019

St. Michael's Hospital to Receive VMS+ 3.0 Whole Heart Analysis System

October 16, 2019

EVENTS

2020- VENTRIPOINT ANNUAL GENERAL MEETING

Virtual On-Line Meeting

December 14, 2020

ASE 2019 - AMERICAN SOCIETY OF ECHO

Portland, OR

June 22-25, 2019 

CSE 2019 - CANADIAN SOCIETY OF ECHO

Toronto, Ontario

April 11-13, 2019 

ACC 2019 - AMERICAN COLLEGE OF CARDIOLOGY ANNUAL CONFERENCE

 

New Orleans, LA

 

March 16-18, 2019

EUROECHO IMAGING 2018 - EUROPEAN SOCIETY OF CARDIOLOGY

Milan, Italy

December 5-8, 2018 

November 24, 2020

Ventripoint Annual General Meeting

2 Sheppard Avenue East, Suite 605

Toronto Ontario M2N 5Y7

Canada

+1-416-848-4156

© 2020 Ventripoint Diagnostics Ltd. All Rights Reserved.

  • Twitter
  • LinkedIn
  • YouTube